ONCOLYZE, INC.

Profile

Company Names

ONCOLYZE, INC.

Addresses

845 UN PLAZA, APT. 61B, ATTN: STEVEN J. EVANS, M.D., NEW YORK, NY 10017

Phone Numbers

917-670-5933

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$425,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-06-22 
$425,000.00 
$527,591.00 
$102,591.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
ABELES 
DIRECTOR
CONTRAFECT CORP   |  NEUROTROPE BIOSCIENCE, INC.   |  NEUROTROPE, INC.   |  CYTOCORE INC   |  ORPHEUS BIOSCIENCE, INC.   |  ONCOLYZE, INC.   |  PATTERN PHARMA INC.
LARRY 
 
ALTSTIEL 
EXECUTIVE OFFICER
VTV THERAPEUTICS INC.   |  ONCOLYZE, INC.   |  PROMIS NEUROSCIENCES INC.
BARBARA 
 
CARLIN 
EXECUTIVE OFFICER
ONCOLYZE, INC.
STEVEN 
J. 
EVANS 
EXECUTIVE OFFICER, DIRECTOR
ONCOLYZE, INC.
JAMES 
 
FOGHT 
DIRECTOR
PINNACLE BIOLOGICS INC   |  PHARMAIN CORP   |  ONCOLYZE, INC.
ROSEMARY 
 
MAZANET 
DIRECTOR
DIABETES AMERICA, INC.   |  CELLUMEN, INC.   |  CERNOSTICS PATHOLOGY, INC.   |  CERNOSTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  COLUMBIA CARE INC.   |  ONCOLYZE, INC.   |  CANNABIST CO HOLDINGS INC.   |  BIOCURIE, INC.
ALEKSANDAR 
 
STOJANOVIC 
EXECUTIVE OFFICER
ONCOLYZE, INC.
ALEXANDER 
 
ZUKIWSKI 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  ONCOLYZE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-07-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-06-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CEROS FINANCIAL SERVICES, INC.
37869